Hyperbaric oxygen therapy improves recovery at acute motor axonal neuropathy case.
Ni Komang Sri Dewi UntariKurnia KusumastutiGuritno SuryokusumoI Ketut SudianaPublished in: Journal of neurosciences in rural practice (2022)
Acute motor axonal neuropathy (AMAN) is a rare immune-mediated disorder characterized by acute flaccid paralysis with elevated levels of GM1 antibodies. It is also known as a subtype of the Guillain-Barre syndrome (GBS) and develops since antigen s serve as antibodies in the spinal cord. We report a case diagnosed as AMAN with symptoms of ascending limb symmetrical weakness. A neurological examination revealed a flaccid paralysis with multiple cranial nerve palsies. Electromyography showed an axonal type of GBS. The patient refused bone marrow fluid aspiration. Intravenous immunoglobulin was administered at the high care unit. Unfortunately, despite the standard therapy, an optimal recovery was not obtained. Hyperbaric oxygen (HBO) therapy has been known to be common in illnesses and some clinical diseases. Although it has not been indicated for peripheral neuropathy, a remarkable recovery was soon visible in the HBO-treated AMAN case. The HBO mechanisms involved here are anti-inflammation and immunomodulation.
Keyphrases
- liver failure
- spinal cord injury
- spinal cord
- respiratory failure
- bone marrow
- aortic dissection
- healthcare
- drug induced
- palliative care
- case report
- mesenchymal stem cells
- hepatitis b virus
- stem cells
- neuropathic pain
- intensive care unit
- high dose
- optic nerve
- low dose
- coronary artery
- cell therapy
- extracorporeal membrane oxygenation
- single cell
- blood brain barrier
- pulmonary arterial hypertension
- smoking cessation
- peripheral nerve
- replacement therapy